panitumumab
amgen,medsir,takeda
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'rectal', 'paradigm', 'colorectal', 'medsir']
very clear and effective discussion of phase iii paradigm by ! fantastic job!
#asco22 #mcrc #colorectalcancer 
Bring your idea to life?? 
Creating successful IITs & optimizing drug development ?? 
Medica Scientia Innovation Research
 ????&????
https://t.co/yp3O5Lylqc